ArticleNPJ breast cancer2023

Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors.

Emma Zattarin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.